NovaBridge Biosciences Income (Loss) from Continuing Operations, Per Basic Share
NovaBridge Biosciences (NBP) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.21 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-04-07
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|
| 2025-12-31 | -$0.21 20-F · filed 2026-04-07 | ||
| 2025-09-30 | -$0.08 6-K · filed 2025-12-18 | ||
| 2025-06-30 | -$0.05 6-K · filed 2025-10-06 | ||
| 2024-12-31 | -$0.27 20-F · filed 2026-04-07 | ||
| 2024-09-30 | -$0.21 6-K · filed 2025-12-18 | ||
| 2024-06-30 | -$0.10 6-K · filed 2025-10-06 | ||
| 2023-12-31 | -$0.43 20-F · filed 2026-04-07 | ||
| 2022-12-31 | -$0.74 20-F · filed 2025-04-03 |